With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.52522-40-4,Tris(dibenzylideneacetone)dipalladium-chloroform,as a common compound, the synthetic route is as follows.
tetrakis(triphenylphosphine)palladium(0) [generated in situ from tris(diphenylmethylideneacetone)dipalladium chloroform adduct (16 mg, 0.016 mmol) and triphenylphosphine 312 mg, 0.12 mmol)] ; tetrakis(triphenylphosphine)palladium (0) [generated in situ from tris(dibenzylideneacetone)dipalladium chloroform adduct (27 mg, 0.025 mmol) and triphenylphosphine (52 mg, 0.20 mmol)]
As the paragraph descriping shows that 52522-40-4 is playing an increasingly important role.
Reference£º
Patent; Universitetet i Olso; US2007/203159; (2007); A1;,
Chapter 1 An introduction to palladium catalysis
Palladium/carbon catalyst regeneration and mechanical application method